Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.632004
Title: Molecular characterisation of focal cortical dysplasia and tuberous sclerosis
Author: Picker, S. R.
ISNI:       0000 0004 5358 6228
Awarding Body: University College London (University of London)
Current Institution: University College London (University of London)
Date of Award: 2014
Availability of Full Text:
Access through EThOS:
Full text unavailable from EThOS. Please try the link below.
Access through Institution:
Abstract:
Introduction: This project focuses on the biological characterisation of 4 important structural causes of severe childhood epilepsy: Focal Cortical Dysplasia (FCD) Type IIb and IIa, and two brain lesions present in Tuberous Sclerosis: cortical tubers and subependymal giant cell astrocytoma (SEGA) tumours. Within these lesions several abnormal cell populations are present, including: Balloon cells, Dysmorphic neurons and SEGA cells. These may represent an aberrant neural progenitor/stem cell population. This raises the hypothesis that a pathological stem cell contributes to the pathogenesis of these diseases. The aim of this study is to identify molecular networks responsible and/or implicated within these lesions. Methods: Differentially expressed genes/exons and microRNAs were identified using the Affymetrix human exon ST1 microarray and NanoString platform respectively. This was performed across the FCD subtypes, cortical tubers, SEGAs and normally formed cortex. WGCNA and IPA network analyses were then applied. Selected proteins based on these results, were validated and investigated by immunohistochemistry of surgical material. Results: Hierarchal clustering of the gene expression between samples was able to reclassify the diseases based on the transcriptome rather than diagnostic subtype. Following a systems biology approach, novel functional networks were identified. A micro-network of: Tenascin C, Palladin, Chitinase-3-like 1, and paired-related-homeobox 1 within the FCD IIb lesion was validated at the protein level, with extracellular-signal-regulated kinase (ERK) as its hub. Additionally, a highly robust subset of alternatively spliced exons specific to the BC harbouring samples were identified. 75.9% of genes identified as differentially expressed between FCD IIa and FCD IIb, were potentially explicable due to the microRNA dysregulation identified. Conclusion: This is the first published gene, exon and microRNA high-throughput analysis performed concurrently for FCD IIb, FCD IIa, cortical tubers and SEGA tumours and the first use of network analysis in these diseases, potentially leading to new therapeutic targets.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.632004  DOI: Not available
Share: